George Litsardakis

Prof. George Litsardakis

orcid

Research Focus & Metrics

Academic Career Length

39Years (1988-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2016 in Journal of Magnetism and Magnetic Materials
Verified
Journal Article
Closed access
CSCharalampos A. Stergiou
Charalampos A. Stergiou
GLGeorge Litsardakis
George Litsardakis

1 September 2007 in Journal of Magnetism and Magnetic Materials
Verified
Journal Article
Closed access
GLGeorge Litsardakis
George Litsardakis
IMIoannis Manolakis
Ioannis Manolakis
CSC. Serletis
C. Serletis
KEK.G. Efthimiadis
K.G. Efthimiadis

1 May 2010 in Journal of Magnetism and Magnetic Materials
Verified
Journal Article
Closed access
CSCharalampos A. Stergiou
Charalampos A. Stergiou
IMIoannis Manolakis
Ioannis Manolakis
TYTraianos V. Yioultsis
Traianos V. Yioultsis
GLGeorge Litsardakis
George Litsardakis

1 September 2007 in Journal of Magnetism and Magnetic Materials
Verified
Journal Article
Closed access
AOA. Oikonomou
A. Oikonomou
Tatiana GiannakopoulouTatiana Giannakopoulou
Tatiana Giannakopoulou
GLGeorge Litsardakis
George Litsardakis

1 January 2007 in Journal of Alloys and Compounds
Verified
Journal Article
Closed access
GLGeorge Litsardakis
George Litsardakis
IMIoannis Manolakis
Ioannis Manolakis
KEK. Efthimiadis
K. Efthimiadis

28 January 2020 in Dalton Transactions
Verified
Journal Article
Closed access
PDF file
Eleftherios HalevasEleftherios Halevas
Eleftherios Halevas
BMBarbara Mavroidi
Barbara Mavroidi
OAOrestis Antonoglou
Orestis Antonoglou
AHAntonios Hatzidimitriou
Antonios Hatzidimitriou
MSMarina Sagnou
Marina Sagnou
MPMaria Pelecanou
Maria Pelecanou
Chemotherapeutic metal-based compounds are effective anticancer agents; however, their cytotoxic profile and significant side effects limit their wide application. Natural products, especially flavonoids, are a prominent alternative source of anticancer agents that can be used as ligands for the generation of new bioactive complexes with metal ions of known biochemical and pharmacological activities. Herein, we present the synthesis and detailed structural and physicochemical characterizations of three novel complex assemblies of Ga(III) with the flavonoid chrysin and the ancillary aromatic chelators 1,10-phenanthroline, 2,2′-bipyridine and imidazole. The complexes constitute the only crystallographically characterized structures having a metal core from the boron group elements and a flavonoid as the ligand. The in vitro biological evaluation of the three complexes in a series of cancer cell lines of different origin established their cytotoxicity and ROS generating potential. In particular, the Ga(III)–chrysin–imidazole complex displayed the highest anticancer efficacy against all cancer cell lines with IC50 values in the low micromolar range (<1.18 μM), a result worth further investigation.